Logo Logo

Publications by Erber, R.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 2.

Journal article

Nitz, U.; Gluz, O.; Huober, J.; Kreipe, H. H.; Kates, R. E.; Hartmann, A.; Erber, R.; Moustafa, Z.; Scholz, M.; Lisboa, B.; Mohrmann, S.; Möbus, V.; Augustin, D.; Hoffmann, G.; Weiss, E.; Böhmer, S.; Kreienberg, R.; Bois, A. du; Sattler, D.; Thomssen, C.; Kiechle, M.; Jänicke, F.; Wallwiener, D.; Harbeck, N.; Kuhn, W. (2017): Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014). In: Annals of Oncology, Vol. 28, No. 11: p. 2899

Gluz, O.; Liedtke, C.; Huober, J.; Peyro-Saint-Paul, H.; Kates, R. E.; Kreipe, H. H.; Hartmann, A.; Pelz, E.; Erber, R.; Mohrmann, S.; Möbus, V.; Augustin, D.; Hoffmann, G.; Thomssen, C.; Jänicke, F.; Kiechle, M.; Wallwiener, D.; Kuhn, W.; Nitz, U.; Harbeck, N. (2016): Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2-early breast cancer: WSG-AGO EC-Doc Trial. In: Annals of Oncology, Vol. 27, No. 6: pp. 1035-1040

This list was generated on Sun Jul 21 00:45:09 2019 CEST.